Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Nov;110(3):927–928. doi: 10.1111/j.1476-5381.1993.tb13901.x

Evidence for the involvement of a 5-HT4 receptor in the secretory response of human small intestine to 5-HT.

R A Borman 1, D E Burleigh 1
PMCID: PMC2175779  PMID: 8298816

Abstract

5-Hydroxytryptamine increases transmucosal short-circuit current across human isolated small intestinal mucosa. The competitive 5-HT4 antagonist, DAU 6285 evoked a concentration-dependent, dextral and parallel shift of the concentration-response curve to 5-HT, with no alteration of the maximum response. Schild analysis of this antagonism produced a Schild regression with a slope of 1.00 and an apparent pA2 estimate of 6.17. It appears that a 5-HT4 receptor may mediate the short-circuit current response of human small intestinal mucosa to 5-HT.

Full text

PDF
927

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bockaert J., Fozard J. R., Dumuis A., Clarke D. E. The 5-HT4 receptor: a place in the sun. Trends Pharmacol Sci. 1992 Apr;13(4):141–145. doi: 10.1016/0165-6147(92)90051-7. [DOI] [PubMed] [Google Scholar]
  3. Bunce K. T., Elswood C. J., Ball M. T. Investigation of the 5-hydroxytryptamine receptor mechanism mediating the short-circuit current response in rat colon. Br J Pharmacol. 1991 Apr;102(4):811–816. doi: 10.1111/j.1476-5381.1991.tb12257.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burleigh D. E. Loperamide but not morphine has anti-secretory effects in human colon, in vitro. Eur J Pharmacol. 1991 Sep 17;202(2):277–280. doi: 10.1016/0014-2999(91)90305-a. [DOI] [PubMed] [Google Scholar]
  5. Schiavone A., Giraldo E., Giudici L., Turconi M., Sagrada A. DAU 6285: a novel antagonist at the putative 5-HT4 receptor. Life Sci. 1992;51(8):583–592. doi: 10.1016/0024-3205(92)90227-g. [DOI] [PubMed] [Google Scholar]
  6. Scott C. M., Bunce K. T., Spraggs C. F. Investigation of the 5-hydroxytryptamine receptor mediating the 'maintained' short-circuit current response in guinea-pig ileal mucosa. Br J Pharmacol. 1992 Aug;106(4):877–882. doi: 10.1111/j.1476-5381.1992.tb14428.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Waikar M. V., Hegde S. S., Ford A. P., Clarke D. E. Pharmacological analyses of endo-6-methoxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-2,3-dihydro-2-oxo-1 H- benzimidazole-1-carboxylate hydrochloride (DAU 6285) at the 5-hydroxytryptamine4 receptor in the tunica muscularis mucosae of rat esophagus and ileum of guinea pig: role of endogenous 5-hydroxytryptamine. J Pharmacol Exp Ther. 1993 Feb;264(2):654–661. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES